

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 4.73255965 |
| 2 | regulation of chemokine secretion (GO:0090196) | 4.71791736 |
| 3 | nucleotide salvage (GO:0043173) | 4.47669669 |
| 4 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.27067422 |
| 5 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.27067422 |
| 6 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.97196149 |
| 7 | purine nucleotide salvage (GO:0032261) | 3.96702557 |
| 8 | pentose metabolic process (GO:0019321) | 3.81053249 |
| 9 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.79111350 |
| 10 | polyamine biosynthetic process (GO:0006596) | 3.74566291 |
| 11 | cellular response to interleukin-4 (GO:0071353) | 3.73500375 |
| 12 | protein maturation by protein folding (GO:0022417) | 3.66044765 |
| 13 | negative regulation of macrophage differentiation (GO:0045650) | 3.57784241 |
| 14 | purine ribonucleotide transport (GO:0015868) | 3.51618465 |
| 15 | UV protection (GO:0009650) | 3.50487669 |
| 16 | adenine nucleotide transport (GO:0051503) | 3.49325569 |
| 17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.45428712 |
| 18 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.43679340 |
| 19 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.34834715 |
| 20 | protein kinase C signaling (GO:0070528) | 3.27646545 |
| 21 | response to interleukin-4 (GO:0070670) | 3.22936471 |
| 22 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.18056605 |
| 23 | regulation of gonadotropin secretion (GO:0032276) | 3.13574891 |
| 24 | GDP-mannose metabolic process (GO:0019673) | 3.07538820 |
| 25 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.06065084 |
| 26 | formation of translation preinitiation complex (GO:0001731) | 3.02287287 |
| 27 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.02197231 |
| 28 | negative regulation of Notch signaling pathway (GO:0045746) | 2.99349258 |
| 29 | ribosome biogenesis (GO:0042254) | 2.95346372 |
| 30 | hemoglobin metabolic process (GO:0020027) | 2.94251716 |
| 31 | negative regulation of mRNA metabolic process (GO:1903312) | 2.90799292 |
| 32 | response to peptidoglycan (GO:0032494) | 2.83581651 |
| 33 | modulation by virus of host process (GO:0019054) | 2.81303058 |
| 34 | negative regulation of mRNA processing (GO:0050686) | 2.80957344 |
| 35 | activation of MAPKKK activity (GO:0000185) | 2.79286986 |
| 36 | negative regulation of necroptotic process (GO:0060546) | 2.77730209 |
| 37 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.74990465 |
| 38 | positive regulation of macrophage activation (GO:0043032) | 2.73726913 |
| 39 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.73322793 |
| 40 | negative regulation of interferon-gamma production (GO:0032689) | 2.70215040 |
| 41 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.68482163 |
| 42 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.66929893 |
| 43 | histone H4-K8 acetylation (GO:0043982) | 2.65029061 |
| 44 | histone H4-K5 acetylation (GO:0043981) | 2.65029061 |
| 45 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.64978495 |
| 46 | purine nucleotide transport (GO:0015865) | 2.64934638 |
| 47 | nucleoside salvage (GO:0043174) | 2.62263372 |
| 48 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61496538 |
| 49 | polyamine metabolic process (GO:0006595) | 2.59997784 |
| 50 | pentose-phosphate shunt (GO:0006098) | 2.58883512 |
| 51 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.58134397 |
| 52 | pyrimidine nucleoside salvage (GO:0043097) | 2.57855438 |
| 53 | pyrimidine-containing compound salvage (GO:0008655) | 2.57855438 |
| 54 | peptidyl-histidine modification (GO:0018202) | 2.57305041 |
| 55 | regulation of mitochondrial translation (GO:0070129) | 2.55318527 |
| 56 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.54770096 |
| 57 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.53119311 |
| 58 | modulation by symbiont of host cellular process (GO:0044068) | 2.52782416 |
| 59 | viral mRNA export from host cell nucleus (GO:0046784) | 2.50690931 |
| 60 | cellular metabolic compound salvage (GO:0043094) | 2.50319498 |
| 61 | regulation of translation in response to stress (GO:0043555) | 2.49993271 |
| 62 | snRNA metabolic process (GO:0016073) | 2.49425713 |
| 63 | NIK/NF-kappaB signaling (GO:0038061) | 2.48663963 |
| 64 | negative regulation of defense response to virus (GO:0050687) | 2.48572900 |
| 65 | viral protein processing (GO:0019082) | 2.48106621 |
| 66 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.47600217 |
| 67 | rRNA modification (GO:0000154) | 2.47504207 |
| 68 | tRNA methylation (GO:0030488) | 2.44406265 |
| 69 | tRNA modification (GO:0006400) | 2.44081255 |
| 70 | histone arginine methylation (GO:0034969) | 2.43883789 |
| 71 | proline biosynthetic process (GO:0006561) | 2.43793278 |
| 72 | metallo-sulfur cluster assembly (GO:0031163) | 2.43443318 |
| 73 | iron-sulfur cluster assembly (GO:0016226) | 2.43443318 |
| 74 | eyelid development in camera-type eye (GO:0061029) | 2.43200591 |
| 75 | deoxyribonucleotide catabolic process (GO:0009264) | 2.43146543 |
| 76 | NADPH regeneration (GO:0006740) | 2.42880733 |
| 77 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.42765828 |
| 78 | germinal center formation (GO:0002467) | 2.42733595 |
| 79 | base-excision repair, AP site formation (GO:0006285) | 2.42545394 |
| 80 | regulation of macrophage differentiation (GO:0045649) | 2.40696284 |
| 81 | regulation of interleukin-5 production (GO:0032674) | 2.40689112 |
| 82 | negative regulation of RNA splicing (GO:0033119) | 2.40276162 |
| 83 | folic acid metabolic process (GO:0046655) | 2.40237782 |
| 84 | spliceosomal snRNP assembly (GO:0000387) | 2.38210871 |
| 85 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.37927161 |
| 86 | GMP metabolic process (GO:0046037) | 2.36980326 |
| 87 | proteasome assembly (GO:0043248) | 2.36960124 |
| 88 | negative regulation of B cell apoptotic process (GO:0002903) | 2.35352408 |
| 89 | microtubule severing (GO:0051013) | 2.33592811 |
| 90 | tricarboxylic acid metabolic process (GO:0072350) | 2.32988256 |
| 91 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.32912785 |
| 92 | zinc ion transmembrane transport (GO:0071577) | 2.32856951 |
| 93 | rRNA transcription (GO:0009303) | 2.32609616 |
| 94 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.31684295 |
| 95 | regulation of translational fidelity (GO:0006450) | 2.30896350 |
| 96 | peptidyl-arginine N-methylation (GO:0035246) | 2.29350073 |
| 97 | peptidyl-arginine methylation (GO:0018216) | 2.29350073 |
| 98 | deoxyribose phosphate catabolic process (GO:0046386) | 2.29166207 |
| 99 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.29112627 |
| 100 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.28661041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.32118684 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.72795877 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.69467612 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.66564706 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40289069 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34125715 |
| 7 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.32038385 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28700126 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.28262026 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.25431064 |
| 11 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25120795 |
| 12 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20841848 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14486941 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.09900219 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09191361 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.07906788 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07637886 |
| 18 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.01052605 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.94270728 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87218417 |
| 21 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82733206 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78359887 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76612252 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75953048 |
| 25 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.74521903 |
| 26 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.72460247 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72039317 |
| 28 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71385023 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65363574 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63357297 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62765840 |
| 32 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.61177014 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.61112974 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60569216 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60416986 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59142947 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58235699 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58124928 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55966288 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54318392 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53244740 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52883957 |
| 43 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.52064443 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49477814 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48517554 |
| 46 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48498215 |
| 47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47964472 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47274787 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43698259 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42612311 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41993447 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41749392 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39609982 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37777289 |
| 55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37330182 |
| 56 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.37240953 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.36257758 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35921841 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30269490 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28055257 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.27116510 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26889134 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26860779 |
| 64 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26567937 |
| 65 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26443751 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24339341 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22722822 |
| 68 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21554871 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21172838 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18616081 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18601488 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16165309 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15160572 |
| 74 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15091419 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14758243 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14051383 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13185354 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12746949 |
| 79 | * P68_20966046_ChIP-Seq_HELA_Human | 1.11301660 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10936281 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10166587 |
| 82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.09149538 |
| 83 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08660068 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08618088 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06943307 |
| 86 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06225592 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06170202 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06031891 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05585999 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05527805 |
| 91 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05196155 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05109190 |
| 93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05071253 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04517708 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04072448 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03970970 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03432218 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03424897 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03275130 |
| 100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03032238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.34153929 |
| 2 | MP0005451_abnormal_body_composition | 3.31283822 |
| 3 | MP0002132_abnormal_respiratory_system | 3.17769373 |
| 4 | MP0005360_urolithiasis | 3.16825552 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.16383876 |
| 6 | MP0003315_abnormal_perineum_morphology | 3.02596404 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.97149464 |
| 8 | MP0009840_abnormal_foam_cell | 2.83688103 |
| 9 | MP0005670_abnormal_white_adipose | 2.72466751 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.42685608 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.33856872 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.21816530 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.20663381 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.13642473 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.13642473 |
| 16 | MP0008058_abnormal_DNA_repair | 2.10227884 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.89642229 |
| 18 | MP0003111_abnormal_nucleus_morphology | 1.77692755 |
| 19 | MP0003186_abnormal_redox_activity | 1.77201832 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.74935273 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.74507895 |
| 22 | MP0002163_abnormal_gland_morphology | 1.73107787 |
| 23 | MP0002254_reproductive_system_inflammat | 1.67782758 |
| 24 | MP0005501_abnormal_skin_physiology | 1.64908009 |
| 25 | MP0002796_impaired_skin_barrier | 1.56987179 |
| 26 | MP0001270_distended_abdomen | 1.56081934 |
| 27 | MP0003436_decreased_susceptibility_to | 1.53208026 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.49364447 |
| 29 | MP0009764_decreased_sensitivity_to | 1.45552690 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.38470461 |
| 31 | MP0005025_abnormal_response_to | 1.33907586 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.30066448 |
| 33 | MP0002098_abnormal_vibrissa_morphology | 1.28976719 |
| 34 | MP0002723_abnormal_immune_serum | 1.28169795 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.27796491 |
| 36 | MP0002009_preneoplasia | 1.25896594 |
| 37 | MP0002089_abnormal_postnatal_growth/wei | 1.24983081 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.23936227 |
| 39 | MP0002419_abnormal_innate_immunity | 1.20253926 |
| 40 | MP0003303_peritoneal_inflammation | 1.19124282 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.18647145 |
| 42 | MP0005187_abnormal_penis_morphology | 1.18263489 |
| 43 | MP0010307_abnormal_tumor_latency | 1.17857460 |
| 44 | MP0002398_abnormal_bone_marrow | 1.17346643 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.16582442 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.16160578 |
| 47 | MP0001800_abnormal_humoral_immune | 1.15323502 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.14789177 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.13849074 |
| 50 | MP0004233_abnormal_muscle_weight | 1.12946521 |
| 51 | MP0001819_abnormal_immune_cell | 1.12920707 |
| 52 | MP0003724_increased_susceptibility_to | 1.10276581 |
| 53 | MP0008469_abnormal_protein_level | 1.07877367 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.07762687 |
| 55 | MP0003123_paternal_imprinting | 1.07506631 |
| 56 | MP0003786_premature_aging | 1.06662216 |
| 57 | MP0000343_altered_response_to | 1.06514509 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.06385330 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.06300489 |
| 60 | MP0000490_abnormal_crypts_of | 1.06086851 |
| 61 | MP0002429_abnormal_blood_cell | 1.05531857 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.05074393 |
| 63 | MP0002722_abnormal_immune_system | 1.05067444 |
| 64 | MP0008260_abnormal_autophagy | 1.04224276 |
| 65 | MP0009785_altered_susceptibility_to | 1.03512770 |
| 66 | MP0000358_abnormal_cell_content/ | 1.02942588 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.02577023 |
| 68 | MP0000858_altered_metastatic_potential | 0.99094602 |
| 69 | MP0003172_abnormal_lysosome_physiology | 0.99075585 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.98969996 |
| 71 | MP0001764_abnormal_homeostasis | 0.98392646 |
| 72 | MP0000716_abnormal_immune_system | 0.97471125 |
| 73 | MP0003077_abnormal_cell_cycle | 0.97074318 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.94007574 |
| 75 | MP0005387_immune_system_phenotype | 0.93060182 |
| 76 | MP0001790_abnormal_immune_system | 0.93060182 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 0.90337207 |
| 78 | MP0008877_abnormal_DNA_methylation | 0.89989807 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.87595619 |
| 80 | MP0000313_abnormal_cell_death | 0.86723272 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.86171997 |
| 82 | MP0008932_abnormal_embryonic_tissue | 0.84195176 |
| 83 | MP0000703_abnormal_thymus_morphology | 0.80860305 |
| 84 | MP0005365_abnormal_bile_salt | 0.78341705 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.75948748 |
| 86 | MP0005671_abnormal_response_to | 0.75400822 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.74369090 |
| 88 | MP0008873_increased_physiological_sensi | 0.74038633 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.73502381 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.73311214 |
| 91 | MP0000598_abnormal_liver_morphology | 0.71894932 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.71038470 |
| 93 | MP0000467_abnormal_esophagus_morphology | 0.70528888 |
| 94 | MP0000685_abnormal_immune_system | 0.69101267 |
| 95 | MP0000678_abnormal_parathyroid_gland | 0.67605385 |
| 96 | MP0001853_heart_inflammation | 0.67461967 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.67413875 |
| 98 | MP0008004_abnormal_stomach_pH | 0.65205576 |
| 99 | MP0002210_abnormal_sex_determination | 0.65199259 |
| 100 | MP0001730_embryonic_growth_arrest | 0.64846807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Azoospermia (HP:0000027) | 4.27787502 |
| 2 | Petechiae (HP:0000967) | 3.54458551 |
| 3 | Abnormal spermatogenesis (HP:0008669) | 3.36196911 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.27192441 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.24685881 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07388015 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07388015 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07388015 |
| 9 | Prolonged neonatal jaundice (HP:0006579) | 2.94507898 |
| 10 | Hypertensive crisis (HP:0100735) | 2.91143935 |
| 11 | Abnormal gallbladder physiology (HP:0012438) | 2.87722365 |
| 12 | Cholecystitis (HP:0001082) | 2.87722365 |
| 13 | Progressive microcephaly (HP:0000253) | 2.81851315 |
| 14 | Long palpebral fissure (HP:0000637) | 2.80876184 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.74126404 |
| 16 | Testicular atrophy (HP:0000029) | 2.69365978 |
| 17 | Loss of speech (HP:0002371) | 2.67695079 |
| 18 | Microvesicular hepatic steatosis (HP:0001414) | 2.67211869 |
| 19 | Abnormal glycosylation (HP:0012345) | 2.67157832 |
| 20 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.67157832 |
| 21 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.67157832 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.67157832 |
| 23 | Nonimmune hydrops fetalis (HP:0001790) | 2.64414071 |
| 24 | Premature ovarian failure (HP:0008209) | 2.49157121 |
| 25 | Nausea (HP:0002018) | 2.43398956 |
| 26 | Hypokinesia (HP:0002375) | 2.43243032 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41738096 |
| 28 | Progressive muscle weakness (HP:0003323) | 2.41338029 |
| 29 | Ragged-red muscle fibers (HP:0003200) | 2.37146783 |
| 30 | Microretrognathia (HP:0000308) | 2.33590328 |
| 31 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.33000009 |
| 32 | Cellulitis (HP:0100658) | 2.31271716 |
| 33 | Stomatitis (HP:0010280) | 2.29726054 |
| 34 | Purpura (HP:0000979) | 2.28735716 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27721413 |
| 36 | Hepatosplenomegaly (HP:0001433) | 2.26585018 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.19656922 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19098716 |
| 39 | Myopathic facies (HP:0002058) | 2.19036714 |
| 40 | Increased serum ferritin (HP:0003281) | 2.16434694 |
| 41 | Prostate neoplasm (HP:0100787) | 2.15045220 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.14377885 |
| 43 | Deformed sella turcica (HP:0002681) | 2.11839524 |
| 44 | Fatigue (HP:0012378) | 2.11471308 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.11440502 |
| 46 | Anorexia (HP:0002039) | 2.09675398 |
| 47 | Hand muscle atrophy (HP:0009130) | 2.06775050 |
| 48 | Thrombocytosis (HP:0001894) | 2.06175299 |
| 49 | Flattened epiphyses (HP:0003071) | 2.05529053 |
| 50 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04618860 |
| 51 | Progressive external ophthalmoplegia (HP:0000590) | 2.04202529 |
| 52 | Vertebral compression fractures (HP:0002953) | 1.98274213 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97862597 |
| 54 | Obstructive lung disease (HP:0006536) | 1.97862597 |
| 55 | Small epiphyses (HP:0010585) | 1.97188511 |
| 56 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.96816493 |
| 57 | Single umbilical artery (HP:0001195) | 1.96816493 |
| 58 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.96816493 |
| 59 | Abnormality of macrophages (HP:0004311) | 1.96322297 |
| 60 | Squamous cell carcinoma (HP:0002860) | 1.95507100 |
| 61 | Upper limb amyotrophy (HP:0009129) | 1.95167591 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 1.95167591 |
| 63 | Abnormal number of erythroid precursors (HP:0012131) | 1.94882610 |
| 64 | Spastic paraparesis (HP:0002313) | 1.94329221 |
| 65 | Diaphragmatic weakness (HP:0009113) | 1.93411919 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 1.93327615 |
| 67 | Increased muscle lipid content (HP:0009058) | 1.91608087 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88501576 |
| 69 | Broad distal phalanx of finger (HP:0009836) | 1.87885331 |
| 70 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87402957 |
| 71 | Recurrent abscess formation (HP:0002722) | 1.86877241 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 1.86039839 |
| 73 | Depressed nasal tip (HP:0000437) | 1.85196382 |
| 74 | Myositis (HP:0100614) | 1.85084452 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 1.84335065 |
| 76 | Aplastic anemia (HP:0001915) | 1.84306561 |
| 77 | Erythema (HP:0010783) | 1.83728086 |
| 78 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83080078 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 1.82626368 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82626368 |
| 81 | Trismus (HP:0000211) | 1.82504480 |
| 82 | Pancytopenia (HP:0001876) | 1.82257037 |
| 83 | Abnormality of the umbilical cord (HP:0010881) | 1.82138135 |
| 84 | Secondary amenorrhea (HP:0000869) | 1.81926962 |
| 85 | Carpal bone hypoplasia (HP:0001498) | 1.80929753 |
| 86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.80009295 |
| 87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.80009295 |
| 88 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79584504 |
| 89 | Epistaxis (HP:0000421) | 1.79369457 |
| 90 | Abnormal number of incisors (HP:0011064) | 1.78253893 |
| 91 | Gastrointestinal infarctions (HP:0005244) | 1.78200534 |
| 92 | Entropion (HP:0000621) | 1.78155428 |
| 93 | Dysostosis multiplex (HP:0000943) | 1.78018627 |
| 94 | Brushfield spots (HP:0001088) | 1.76871013 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.76714983 |
| 96 | Broad face (HP:0000283) | 1.76396599 |
| 97 | Polygenic inheritance (HP:0010982) | 1.71434843 |
| 98 | Mitral stenosis (HP:0001718) | 1.71297711 |
| 99 | Methylmalonic aciduria (HP:0012120) | 1.70366896 |
| 100 | Poor eye contact (HP:0000817) | 1.68443940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.09284735 |
| 2 | NME2 | 3.41547735 |
| 3 | TESK2 | 3.36610804 |
| 4 | ERN1 | 2.94765201 |
| 5 | SMG1 | 2.73083982 |
| 6 | BCKDK | 2.60348773 |
| 7 | PIM2 | 2.51546032 |
| 8 | IRAK3 | 2.49939629 |
| 9 | TNK2 | 2.12187947 |
| 10 | CLK1 | 2.10054430 |
| 11 | PRPF4B | 2.08641831 |
| 12 | VRK2 | 1.99995754 |
| 13 | STK16 | 1.98743643 |
| 14 | TAOK2 | 1.94859335 |
| 15 | SIK1 | 1.94733657 |
| 16 | ZAK | 1.69412341 |
| 17 | IRAK4 | 1.62156793 |
| 18 | TESK1 | 1.59077189 |
| 19 | MAP3K11 | 1.59031078 |
| 20 | IKBKB | 1.58862510 |
| 21 | MAP3K3 | 1.58343435 |
| 22 | MAP2K3 | 1.54615241 |
| 23 | IRAK2 | 1.52072961 |
| 24 | AURKA | 1.50151944 |
| 25 | CDK9 | 1.48028315 |
| 26 | TRIB3 | 1.46145604 |
| 27 | CDK7 | 1.45091665 |
| 28 | TLK1 | 1.42986886 |
| 29 | BUB1 | 1.42765583 |
| 30 | MAP4K1 | 1.39541241 |
| 31 | TBK1 | 1.38991645 |
| 32 | EPHA2 | 1.37419530 |
| 33 | ICK | 1.31852792 |
| 34 | STK4 | 1.29899604 |
| 35 | MAP3K1 | 1.27864819 |
| 36 | MAPK11 | 1.17707663 |
| 37 | TAOK1 | 1.12769723 |
| 38 | MAP3K8 | 1.11017376 |
| 39 | PRKG2 | 1.10605949 |
| 40 | JAK3 | 1.05883919 |
| 41 | SIK2 | 1.03290618 |
| 42 | KDR | 1.00920493 |
| 43 | PAK4 | 1.00343227 |
| 44 | CDK4 | 0.97132313 |
| 45 | IKBKE | 0.96117300 |
| 46 | DYRK3 | 0.95976399 |
| 47 | PASK | 0.94474294 |
| 48 | ABL2 | 0.92321693 |
| 49 | CDK19 | 0.86877451 |
| 50 | SCYL2 | 0.86495765 |
| 51 | MAP3K10 | 0.83074825 |
| 52 | EPHB1 | 0.82449059 |
| 53 | CDK8 | 0.81472288 |
| 54 | DYRK1B | 0.80501724 |
| 55 | LIMK1 | 0.77867633 |
| 56 | STK10 | 0.77750743 |
| 57 | CDK12 | 0.76935634 |
| 58 | PRKCI | 0.76880651 |
| 59 | TAOK3 | 0.74151357 |
| 60 | RPS6KA5 | 0.71088738 |
| 61 | MAP2K7 | 0.70391943 |
| 62 | PDK2 | 0.69584700 |
| 63 | CHEK2 | 0.68987381 |
| 64 | PIM1 | 0.68520036 |
| 65 | GRK6 | 0.67991293 |
| 66 | SRPK1 | 0.65988394 |
| 67 | RIPK4 | 0.64296064 |
| 68 | ATR | 0.63485546 |
| 69 | SIK3 | 0.59854607 |
| 70 | RPS6KB2 | 0.55762968 |
| 71 | PDPK1 | 0.55184709 |
| 72 | PRKD2 | 0.54827189 |
| 73 | PAK1 | 0.54380401 |
| 74 | FER | 0.53618908 |
| 75 | TYK2 | 0.53013327 |
| 76 | LRRK2 | 0.51443794 |
| 77 | VRK1 | 0.50285678 |
| 78 | BMPR2 | 0.50241466 |
| 79 | CHEK1 | 0.50184468 |
| 80 | MAP3K14 | 0.49622452 |
| 81 | AURKB | 0.48949972 |
| 82 | IRAK1 | 0.48195625 |
| 83 | MTOR | 0.48040448 |
| 84 | FGFR4 | 0.47461596 |
| 85 | CHUK | 0.45930065 |
| 86 | FGR | 0.44757607 |
| 87 | PRKCQ | 0.44490184 |
| 88 | BRD4 | 0.42834742 |
| 89 | CSNK1G3 | 0.41377783 |
| 90 | GSK3A | 0.40203307 |
| 91 | CSK | 0.37886088 |
| 92 | CSF1R | 0.36937121 |
| 93 | MATK | 0.36831278 |
| 94 | DAPK3 | 0.36765269 |
| 95 | CDC42BPA | 0.36348775 |
| 96 | MAP3K5 | 0.36280313 |
| 97 | CSNK2A2 | 0.35606272 |
| 98 | CAMK2G | 0.32513200 |
| 99 | AKT2 | 0.32093734 |
| 100 | CSNK2A1 | 0.31577156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.32784883 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.24720373 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.12206117 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48416360 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.24140227 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.09112182 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.99690267 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.97013991 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.94758155 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.94051397 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.84676105 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.84087242 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.83175083 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 1.77033956 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72375682 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.69331871 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68712913 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.66569265 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64396344 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62251477 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.60259807 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60028690 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58398741 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.57213894 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.54256783 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50560536 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.49099415 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46877553 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45898625 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44739637 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44667486 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.41661724 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30902196 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23645030 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19678243 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17570846 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.16968413 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.14705347 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10541110 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07049311 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05394547 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04954603 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03637085 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02777575 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01873786 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.01479437 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98290574 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95837523 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91916706 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91904910 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88836266 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84359319 |
| 53 | Cell cycle_Homo sapiens_hsa04110 | 0.83965870 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82221693 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.81999743 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80986772 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.79648703 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79438769 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78364146 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77078712 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76285131 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75554088 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74186309 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73804923 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73755121 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73442777 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73320854 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71774243 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71305243 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.68443976 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64856201 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64780032 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63617829 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63005687 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62120620 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61575247 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.60834568 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.57572747 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.56338053 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54817095 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53178999 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.52226822 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51723846 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50531412 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49317152 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48741142 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47253871 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47158098 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.46853688 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45743890 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.45363991 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45285931 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45015273 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44478137 |
| 95 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43210146 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43170263 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42734258 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39475198 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39298941 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.38070467 |

